[
  {
    "ts": "2026-02-19T12:02:12+00:00",
    "headline": "J&J to build $1bn US CGT manufacturing site in Pennsylvania",
    "summary": "The Pennsylvania site is one of four US-based manufacturing sites J&J plans to build over the next four years.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-1bn-cell-therapy-manufacturing-site-pennsylvania/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "5ae0c4e5-aa19-3ad7-986f-c6139ce39eab",
      "content": {
        "id": "5ae0c4e5-aa19-3ad7-986f-c6139ce39eab",
        "contentType": "STORY",
        "title": "J&J to build $1bn US CGT manufacturing site in Pennsylvania",
        "description": "",
        "summary": "The Pennsylvania site is one of four US-based manufacturing sites J&J plans to build over the next four years.",
        "pubDate": "2026-02-19T12:02:12Z",
        "displayTime": "2026-02-19T12:02:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e",
          "originalWidth": 1000,
          "originalHeight": 623,
          "caption": "J&J's Pennsylvania expansion falls in line with the wider industry trend towards onshoring drug manufacturing to the US. Credit: Skorzewiak/ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xhSGSFHrgmGMG5le43kxow--~B/aD02MjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e.cf.webp",
              "width": 1000,
              "height": 623,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6Oz2h4xghDpqu0JklEVAhw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-1bn-cell-therapy-manufacturing-site-pennsylvania/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-build-1bn-us-120212877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T15:15:00+00:00",
    "headline": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
    "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
    "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
      "content": {
        "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
        "contentType": "STORY",
        "title": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
        "description": "",
        "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
        "pubDate": "2026-02-19T15:15:00Z",
        "displayTime": "2026-02-19T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T19:41:30+00:00",
    "headline": "Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports",
    "summary": "Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on",
    "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
      "content": {
        "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
        "contentType": "STORY",
        "title": "Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports",
        "description": "",
        "summary": "Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on",
        "pubDate": "2026-02-19T19:41:30Z",
        "displayTime": "2026-02-19T19:41:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023.  REUTERS/Brendan McDermid/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yf_TaZ9BDBcKAT4tF0Mdeg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C0U47APrhlqNbWby_gbA.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T19:49:43+00:00",
    "headline": "Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports",
    "summary": "Feb 19 () - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has ‌been planning to separate, with big buyout firms already ‌circling, Bloomberg News reported on Thursday, citing people familiar with the matter. The ​business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, according to Bloomberg.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
      "content": {
        "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
        "contentType": "STORY",
        "title": "Johnson & Johnson explores $20 billion sale of orthopedics unit, Bloomberg News reports",
        "description": "",
        "summary": "Feb 19 () - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has ‌been planning to separate, with big buyout firms already ‌circling, Bloomberg News reported on Thursday, citing people familiar with the matter. The ​business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, according to Bloomberg.",
        "pubDate": "2026-02-19T19:49:43Z",
        "displayTime": "2026-02-19T19:49:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/f62f6be643a37e993ec0abe15e212c99",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023.  REUTERS/Brendan McDermid/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GR1PFqq2jpTzKWovzCjHkw--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f62f6be643a37e993ec0abe15e212c99.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PpuVDHbl6lpDWWOkI1JecQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/f62f6be643a37e993ec0abe15e212c99.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T19:16:27+00:00",
    "headline": "J&J Explores $20 Billion-Plus Sale of Orthopedics Unit",
    "summary": "The business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, the people said, asking not to be identified discussing confidential information.  J&J is assembling documents and financials for DePuy Synthes before it meets with possible buyers in the coming weeks, the people said.  Several large private equity firms are considering teaming up to potentially buy out the unit, they said.",
    "url": "https://finance.yahoo.com/news/j-j-explores-20-billion-191627317.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "8de2da68-1d23-358a-ac66-0341ae4342a4",
      "content": {
        "id": "8de2da68-1d23-358a-ac66-0341ae4342a4",
        "contentType": "STORY",
        "title": "J&J Explores $20 Billion-Plus Sale of Orthopedics Unit",
        "description": "",
        "summary": "The business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, the people said, asking not to be identified discussing confidential information.  J&J is assembling documents and financials for DePuy Synthes before it meets with possible buyers in the coming weeks, the people said.  Several large private equity firms are considering teaming up to potentially buy out the unit, they said.",
        "pubDate": "2026-02-19T19:16:27Z",
        "displayTime": "2026-02-19T19:16:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/ff4b1731a799003205ae080500659679",
          "originalWidth": 2000,
          "originalHeight": 1334,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7Jp7X3AtoB6d_LU.8J2YeA--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/ff4b1731a799003205ae080500659679.cf.webp",
              "width": 2000,
              "height": 1334,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6oS2fQ2fDrasUxN4Mglakw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/ff4b1731a799003205ae080500659679.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-explores-20-billion-191627317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-explores-20-billion-191627317.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "HOLX"
            },
            {
              "symbol": "TPG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T18:34:17+00:00",
    "headline": "Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility",
    "summary": "Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.",
    "url": "https://www.foxbusiness.com/markets/johnson-johnson-invest-1b-pennsylvania-manufacturing-facility",
    "source": "Fox Business",
    "provider": "yfinance",
    "raw": {
      "id": "425ed03a-7da0-3beb-b578-85533b07713f",
      "content": {
        "id": "425ed03a-7da0-3beb-b578-85533b07713f",
        "contentType": "STORY",
        "title": "Johnson & Johnson to invest $1B in Pennsylvania manufacturing facility",
        "description": "",
        "summary": "Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.",
        "pubDate": "2026-02-19T18:34:17Z",
        "displayTime": "2026-02-19T18:34:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/fox_business_text_367/858b7de755d191a1c62d854937e472aa",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2rR5bTVvxlPm_DvpcfOjfg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/fox_business_text_367/858b7de755d191a1c62d854937e472aa.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PE6olJESF4DtnlMZTymbOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/fox_business_text_367/858b7de755d191a1c62d854937e472aa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Fox Business",
          "url": "https://www.foxbusiness.com/"
        },
        "canonicalUrl": {
          "url": "https://www.foxbusiness.com/markets/johnson-johnson-invest-1b-pennsylvania-manufacturing-facility",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-invest-1b-pennsylvania-183417009.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T21:10:00+00:00",
    "headline": "Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board",
    "summary": "WESTPORT, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand and subsidiary of Compass Diversified (NYSE: CODI) (“CODI”), announces the appointment of Janis Smith-Gomez as Chair of its Board of Directors, effective January 1, 2026. Ms. Smith-Gomez joined the Company’s Board in April 2024 and has brought commercial and marketing expertise developed through leadership roles across consumer goods",
    "url": "https://finance.yahoo.com/news/compass-diversified-subsidiary-honey-pot-211000761.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "bd0ab6e7-6896-344c-b2df-e3e3ab3155ab",
      "content": {
        "id": "bd0ab6e7-6896-344c-b2df-e3e3ab3155ab",
        "contentType": "STORY",
        "title": "Compass Diversified Subsidiary The Honey Pot Co. Announces Appointment of Janis Smith-Gomez as Chair of the Board",
        "description": "",
        "summary": "WESTPORT, Conn., Feb. 19, 2026 (GLOBE NEWSWIRE) -- The Honey Pot Company, LLC (“The Honey Pot Co.” or “the Company”), a leading “better-for-you” feminine care brand and subsidiary of Compass Diversified (NYSE: CODI) (“CODI”), announces the appointment of Janis Smith-Gomez as Chair of its Board of Directors, effective January 1, 2026. Ms. Smith-Gomez joined the Company’s Board in April 2024 and has brought commercial and marketing expertise developed through leadership roles across consumer goods",
        "pubDate": "2026-02-19T21:10:00Z",
        "displayTime": "2026-02-19T21:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d2245f6a438451e73a324c3ffef13b22",
          "originalWidth": 576,
          "originalHeight": 576,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6WYR1liB.eNirc8.iOLaBA--~B/aD01NzY7dz01NzY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d2245f6a438451e73a324c3ffef13b22.cf.webp",
              "width": 576,
              "height": 576,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q1Yfk69x_FntmoA7QRieGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d2245f6a438451e73a324c3ffef13b22.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/compass-diversified-subsidiary-honey-pot-211000761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/compass-diversified-subsidiary-honey-pot-211000761.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CODI"
            },
            {
              "symbol": "CODI-PA"
            },
            {
              "symbol": "CODI-PB"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PEP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]